Norovirus capsid and rotavirus VP6 protein for use as combined ...

Norovirus capsid and rotavirus VP6 protein for use as combined vaccine. Cite. Download. Patent. US-8895015-B2. Inventor. VESIKARI TIMO (FI). BLAZEVIC VESNA (FI).

US20120093884A1 - Norovirus capsid and rotavirus vp6 protein for ...

The present invention relates to a combined norovirus and rotavirus vaccine for prevention of norovirus and rotavirus infection and/or viral-induced ...

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for ...

The proteins VP7 and VP4 contain neutralizing epitopes and induce protective immunity based on neutralizing antibodies (N-Ab) [11]. The major capsid protein VP6 ...

MX2013004159A - Norovirus capsid and rotavirus vp6 protein for ...

Norovirus capsid and rotavirus vp6 protein for use as combined vaccine. Abstract. translated from. The present invention relates to a combined norovirus and ...

norovirus capsid and rotavirus vp6 protein for use as combined ...

More specifically, the invention comprises a method ofpreparing combination vaccine compositions comprising norovirus and rotavirus antigens, in ...

NOROVIRUS CAPSID AND ROTAVIRUS VP6 PROTEIN FOR USE ...

... Gazette 2012/16). (54) NOROVIRUS CAPSID AND ROTAVIRUS VP6 PROTEIN FOR USE AS COMBINED VACCINE. NOROVIRUS-KAPSID UND ROTAVIRUS-VP6-PROTEIN ZUR VERWENDUNG ALS.

Full article: Rotavirus capsid VP6 protein acts as an adjuvant in vivo ...

Rotavirus (RV) and norovirus (NoV) are the 2 leading causes of acute viral gastroenteritis worldwide. We have developed a non-live NoV and RV vaccine ...

Generation of Recombinant Rotaviruses Expressing Human ...

In countries where rotavirus vaccines are widely used, norovirus (NoV) has emerged as the major cause of acute gastroenteritis. Towards the goal ...

Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine ... - MDPI

Rotaviruses (RVs) and noroviruses (NoVs) are major causes of childhood acute gastroenteritis. During development of a combination vaccine ...

Norovirus VLPs and Rotavirus VP6 as combined vaccine for ...

... RV inner capsid protein VP6 is considered a potential vaccine candidate due to its extremely immunogenic and polymorphic nature, being able ...

Unravelling aggregation propensity of rotavirus A VP6 expressed as ...

The inner capsid protein of rotavirus, VP6, emerges as a promising candidate for next-generation vaccines against rotaviruses owing to its ...

Combination of three virus-derived nanoparticles as a vaccine ...

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis ... Rotavirus capsid VP6 protein acts as an ...

Rotavirus capsid VP6 tubular and spherical nanostructures act as ...

A subunit protein vaccine candidate based on norovirus (NoV) virus-like particles (VLPs) and rotavirus (RV) VP6 protein against acute childhood gastroenteritis ...

Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus‐Like Particle ...

We have previously shown that rotavirus (RV) inner capsid protein VP6 has an adjuvant effect on norovirus (NoV) virus-like particle- (VLP-) ...

Production of norovirus-, rotavirus-, and enterovirus-like particles in ...

4/Sydney/NSW0514/2012/AU (GenBank ID: AFV08795), rotavirus inner capsid protein VP6 ... Norovirus VLPs and rotavirus VP6 protein as combined ...

Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations ...

This study explored an immunostimulatory effect of VP6 nanospheres on smaller antigens, P particles formed by protruding domain of a norovirus capsid protein.

Norovirus Vaccine: One Step Closer - Oxford Academic

4 Farmington by 19 amino acids in the hypervariable domain of the norovirus capsid protein. ... Norovirus VLPs and rotavirus VP6 protein as combined vaccine for ...

Rotavirus VP6: involvement in immunogenicity, adjuvant activity ...

The highly conserved structural protein VP6 is highly immunogenic, and it can generate self-assembled nano-sized structures, including tubes and spheres (virus ...

(PDF) Rotavirus capsid VP6 protein acts as an adjuvant in vivo for ...

PDF | Rotavirus (RV) and norovirus (NoV) are the two leading causes of acute viral gastroenteritis worldwide. We have developed a non-live NoV and RV.

Mucosal and systemic neutralizing antibodies to norovirus induced ...

Here, we successfully induced systemic and mucosal antibody responses against both rotavirus and norovirus following inoculation of recombinant rotaviruses ...